SeaStar Medical Holding Corporation Share Price & Technical Analysis
ICU · $3.28 (-7.08%)
Healthcare / Biotechnology
$3.28
-7.08%
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperin…
Price chart
Seasonality
Jun has 1 positive and 4 negative years (last 5 years shown)
-13% return in Jun, -30% avg return in past 3 year Jun month.
43% return in 2026, -105% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 17% | 37% | 14% | -12% | -13% | – | – | – | – | – | – | 43% |
| 25 | 13% | -25% | -4% | -23% | -7% | -64% | 49% | 51% | -39% | 2% | -47% | -23% | -117% |
| 24 | 82% | -14% | -7% | -36% | -24% | -21% | 11% | -45% | -14% | -26% | -21% | -23% | -138% |
| 23 | 2% | -23% | -37% | 16% | -76% | -4% | 3% | -48% | 2% | 151% | -33% | -12% | -60% |
| 22 | 0% | 1% | 1% | 0% | 0% | 0% | 0% | 0% | 1% | 6% | -54% | -7% | -52% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$14.35M
P/E ratio
—
52W high
$13.00
52W low
$2.07
Volume
98,784
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is SeaStar Medical Holding Corporation share price today?
- SeaStar Medical Holding Corporation (ICU) last traded around $3.28 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ICU have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ICU. Download the app for real-time alerts.
- How can I analyze SeaStar Medical Holding Corporation stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.